AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+3.49%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$14.5B
AUM Growth
+$941M
(+6.9%)
Cap. Flow
+$1.14B
Cap. Flow
% of AUM
7.88%
Top 10 Holdings %
Top 10 Hldgs %
50.76%
Holding
909
New
194
Increased
274
Reduced
256
Closed
181
Top Buys
| 1 |
RMP
Rice Midstream Partners LP
RMP
|
$122M |
| 2 |
ETP
Energy Transfer Partners L.p.
ETP
|
$84.9M |
| 3 |
Enterprise Products Partners
EPD
|
$82.9M |
| 4 |
Plains All American Pipeline
PAA
|
$73.3M |
| 5 |
WES
Western Gas Partners Lp
WES
|
$58.1M |
Top Sells
| 1 |
Pitney Bowes
PBI
|
$36.3M |
| 2 |
FTR
Frontier Communications Corp.
FTR
|
$34.8M |
| 3 |
Brookfield
BN
|
$32.6M |
| 4 |
Royal Gold
RGLD
|
$16M |
| 5 |
Danaher
DHR
|
$12.5M |
Sector Composition
| 1 | Energy | 65.56% |
| 2 | Materials | 2.69% |
| 3 | Financials | 2.68% |
| 4 | Healthcare | 2.39% |
| 5 | Technology | 2.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
676
Adaptimmune Therapeutics
ADAP
$10.9M
| $336K | ﹤0.01% |
60,896
-7,128
| -10% | -$39.3K |
|
677
Neurogene
NGNE
$285M
| $336K | ﹤0.01% |
1,008
-117
| -10% | -$39K |
|
678
Progressive
PGR
$143B
| $336K | ﹤0.01% |
+8,586
| New | +$336K |
|
679
Expeditors International
EXPD
$16.4B
| $332K | ﹤0.01% |
5,874
+1,289
| +28% | +$72.9K |
|
|
ADMS
680
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $331K | ﹤0.01% |
18,910
-2,215
| -10% | -$38.8K |
|
681
Alphabet (Google) Class A
GOOGL
$2.84T
| $327K | ﹤0.01% |
7,720
-19,920
| -72% | -$844K |
|
|
CNCE
682
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $327K | ﹤0.01% |
19,162
-2,244
| -10% | -$38.3K |
|
683
American Express
AXP
$227B
| $325K | ﹤0.01% |
+4,113
| New | +$325K |
|
|
MDP
684
DELISTED
Meredith Corporation
MDP
| $325K | ﹤0.01% |
+5,034
| New | +$325K |
|
|
PARA
685
DELISTED
Paramount Global Class B
PARA
| $318K | ﹤0.01% |
+4,587
| New | +$318K |
|
|
OTIC
686
DELISTED
Otonomy, Inc.
OTIC
| $318K | ﹤0.01% |
25,976
-3,038
| -10% | -$37.2K |
|
|
BGC
687
DELISTED
General Cable Corporation
BGC
| $318K | ﹤0.01% |
+17,707
| New | +$318K |
|
688
Sysco
SYY
$39.4B
| $316K | ﹤0.01% |
+6,080
| New | +$316K |
|
689
Akebia Therapeutics
AKBA
$785M
| $303K | ﹤0.01% |
32,970
-3,860
| -10% | -$35.5K |
|
|
CCXI
690
DELISTED
ChemoCentryx, Inc.
CCXI
| $299K | ﹤0.01% |
41,127
-4,815
| -10% | -$35K |
|
691
Old Republic International
ORI
$10.1B
| $298K | ﹤0.01% |
+14,558
| New | +$298K |
|
692
Target
TGT
$42.3B
| $297K | ﹤0.01% |
+5,377
| New | +$297K |
|
|
WRI
693
DELISTED
Weingarten Realty Investors
WRI
| $294K | ﹤0.01% |
9,761
-1,591
| -14% | -$47.9K |
|
|
LHO
694
DELISTED
LaSalle Hotel Properties
LHO
| $294K | ﹤0.01% |
+11,123
| New | +$294K |
|
|
OMED
695
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $294K | ﹤0.01% |
31,910
-3,735
| -10% | -$34.4K |
|
696
PTC Therapeutics
PTCT
$4.55B
| $291K | ﹤0.01% |
29,524
-3,455
| -10% | -$34.1K |
|
697
Jack in the Box
JACK
$386M
| $287K | ﹤0.01% |
+2,822
| New | +$287K |
|
698
Citigroup
C
$176B
| $278K | ﹤0.01% |
4,655
-7,694
| -62% | -$459K |
|
699
Fifth Third Bancorp
FITB
$30.2B
| $274K | ﹤0.01% |
10,790
-13,681
| -56% | -$347K |
|
700
Northern Trust
NTRS
$24.3B
| $265K | ﹤0.01% |
+3,063
| New | +$265K |
|